VARIANTYX  POSTS

Cancer predisposition variants: looking beyond BRCA1/2

It’s important to understand that direct-to-consumer testing services like 23andMe and others look at only a small number of variants for each condition. For BRCA1 and BRCA2, that number can be as low as only 3 variants when thousands more have been identified.

Read More

September is Healthy Aging Month!

Because it’s never too early or too late to ensure we’re on the right path with our health, we’re using the Healthy Aging Month campaign to take a look at the important benefits of proactive genetic testing.

Read More

Spotlight on Huntington’s disease

Huntington’s disease is caused by expansion of the CAG repeat in the Huntington (HTT) gene, which is one of more than 20 tandem repeat expansions analyzed by the Genomic Unity™ test.

Read More

Spotlight on hereditary peripheral neuropathies

There are a number of neuropathies that are genetic in origin. They may be inherited in an autosomal dominant, autosomal recessive or X-linked manor. They may also arise de novo.

Read More

Spotlight on autism spectrum disorders

A diagnosis of autism spectrum disorder specifies that the patient meets behavioral criteria that define and describe the disorder, but doesn’t specify why. Genetic testing can help identify the molecular cause in 20-25% of children with autism spectrum disorder.

Read More

Variantyx Inc.

1671 Worcester Road, Suite 300
Framingham MA 01701 USA

Phone: +1 617-209-2090

  • This site is protected by reCAPTCHA and the Google Privacy and Terms of Service apply